Triochem products Limited has filed its quarterly compliance confirmation with BSE Limited under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended March 31, 2026. The submission addresses the company's obligations under Regulation 57(5) regarding non-convertible securities.

Regulatory Compliance Status

The company confirmed its compliance status through a formal communication dated April 16, 2026, with reference number TPL PP 20260333 2026. The compliance covers two specific requirements under Regulation 57(5) of SEBI regulations.

Key Details

Triochem Products Limited stated that both compliance requirements are not applicable to the company as it has not issued any non-convertible securities. This means:

• No certificate submission required for payment of interest, dividend, or principal obligations
• No certificate submission required for details of unpaid obligations
• The company maintains a clean compliance record with no outstanding non-convertible securities obligations

Corporate Information

The compliance document was signed by Ureca Deolekar, Company Secretary & Compliance Officer, and submitted to BSE Limited at Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai. The company trades on BSE under scrip code 512101.

Regulatory Framework

Regulation 57(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 requires listed companies to submit quarterly compliance certificates regarding their non-convertible securities obligations. This ensures transparency and regulatory oversight of debt securities issued by listed entities.

Triochem Products Limited has successfully completed its separate Board Meeting of Independent Directors on March 20, 2026, in compliance with regulatory requirements. The meeting concluded at 4:10 PM after comprehensive deliberations on key governance matters.

Meeting Outcome and Regulatory Compliance

The independent directors' meeting was conducted under Regulation 25(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provisions of Section 173 and Schedule IV of the Companies Act, 2013. The meeting was held on Friday, March 20, 2026, commencing at 3:00 PM and concluding at 4:10 PM at the company's registered office.

Key Agenda Items Addressed

The independent directors successfully deliberated on three critical governance matters during the meeting. The comprehensive review process covered multiple aspects of board effectiveness and organizational performance.

The meeting addressed the following key areas:

• Review of the performance of Non-Independent Directors and the Board as a whole
• Review of the performance of the Chairperson of the Company
• Assessment of the quality, quantity and timeliness of flow of information between company management and the Board necessary for effective performance of duties

Corporate Governance Milestone

This completed meeting represents a significant governance milestone for the Mumbai-based chemical products company. The evaluation process ensures independent oversight of board performance and management effectiveness, with particular focus on information flow assessment between management and the board.

Company Communication

Triochem Products Limited communicated the meeting outcome to BSE Limited through an official intimation. Company Secretary and Compliance Officer Ureca Deolekar signed the outcome notice, which was digitally authenticated on March 20, 2026. The company maintains its registered office in Mumbai's Fort area and operates through its corporate website at www.triochemproducts.com .